tirzepatidePapers
Papers about tirzepatide
- papers
- 321
Newest first
151 to 200 of 321Every paper here, unless its row says otherwiseIndexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide
Revisional endoscopic sleeve gastroplasty versus semaglutide and tirzepatide for weight recidivism after sleeve gastrectomy.
Clinical obesity2025PMID 39909715Indexed under tirzepatide in PubMed's chemical list
Safety and Efficacy of Tirzepatide in Solid-Organ Transplant Recipients: Experience of a Quaternary Care Center in the Middle East.
Experimental and clinical transplantation2025PMID 39918190
Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.
Endocrinology, diabetes & metabolism2025PMID 39949069
Tackling suboptimal clinical response after metabolic bariatric surgery: Impact of tirzepatide on weight loss and body composition.
Obesity research & clinical practice2025PMID 39952885
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.
Diabetes, obesity & metabolism2025PMID 39996356
Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database.
Diabetes, obesity & metabolism2025PMID 39996368Also indexed under tirzepatide as a PubMed major topic
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
The lancet. Diabetes & endocrinology2025PMID 40031941Also indexed under tirzepatide as a PubMed major topic
Tirzepatide and major adverse limb events: Insights from a multicenter real-world analysis in PAD and diabetes patients.
Diabetes research and clinical practice2025PMID 40049522
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States.
Diabetes & metabolism2025PMID 40057019Also indexed under tirzepatide as a PubMed major topic
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?
Diabetes care2025PMID 40063619
Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program.
Obesity (Silver Spring, Md.)2025PMID 40074721
Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme.
Diabetes, obesity & metabolism2025PMID 40083081
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database.
Diabetes, obesity & metabolism2025PMID 40084533
Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials.
Diabetes & metabolic syndrome2025PMID 40086043Indexed under tirzepatide in PubMed
Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months.
Diabetes technology & therapeutics2025PMID 40098470
Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.
Diabetes care2025PMID 40100982
Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi-institutional propensity score-matched study.
Diabetes, obesity & metabolism2025PMID 40109063
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial.
Journal of the American College of Cardiology2025PMID 40162940
Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States.
Diabetes, obesity & metabolism2025PMID 40181696Also indexed under tirzepatide as a PubMed major topic
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide : A Randomized Clinical Trial.
Annals of internal medicine2025PMID 40183678
Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Direct Comparative Studies.
Endocrinology, diabetes & metabolism2025PMID 40184508Indexed under tirzepatide in PubMed
Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis.
Annals of Saudi medicine2025PMID 40189856Indexed under tirzepatide in PubMed
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.
Cell metabolism2025PMID 40203836
Preliminary Evidence Suggests That a 12-Week Treatment with Tirzepatide Plus Low-Energy Ketogenic Therapy Is More Effective than Its Combination with a Low-Calorie Diet in Preserving Fat-Free Mass, Muscle Strength, and Resting Metabolic Rate in Patients with Obesity.
Nutrients2025PMID 40218974
Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States : A Population-Based Cohort Study.
Annals of internal medicine2025PMID 40228298Also indexed under tirzepatide as a PubMed major topic
Analysis of Tirzepatide Acquisition Costs and Weight Reduction Outcomes in the United Kingdom: Insights from the SURMOUNT-1 Study.
Advances in therapy2025PMID 40251452
Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial.
The lancet. Diabetes & endocrinology2025PMID 40318682Also indexed under tirzepatide as a PubMed major topic
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison.
Diabetes, obesity & metabolism2025PMID 40321113Indexed under tirzepatide in PubMed
Predicting 10-year risk of type 2 diabetes in Chinese people with overweight or obesity treated with Tirzepatide: Post hoc analysis of SURMOUNT-CN trial.
Diabetes, obesity & metabolism2025PMID 40329666Also indexed under tirzepatide as a PubMed major topic
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
The New England journal of medicine2025PMID 40353578Indexed under tirzepatide in PubMed
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial.
Diabetes, obesity & metabolism2025PMID 40365662Also indexed under tirzepatide as a PubMed major topic
Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.
Journal of the American College of Cardiology2025PMID 40368575Also indexed under tirzepatide as a PubMed major topic; tests tirzepatide
Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study.
Nature communications2025PMID 40368924
Glucagon-Like Peptide-1 receptor agonists, dual GIP/GLP-1 receptor agonist tirzepatide and suicidal ideation and behavior: A systematic review of clinical studies and pharmacovigilance reports.
Diabetes & metabolic syndrome2025PMID 40388845
Clinical effectiveness of tirzepatide for patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study.
Diabetes research and clinical practice2025PMID 40412626
Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of SURMOUNT-CN study.
Obesity (Silver Spring, Md.)2025PMID 40437798
Comparative clinical outcomes of adults with obstructive sleep apnea and comorbid obesity receiving tirzepatide versus bariatric metabolic surgery: A Multi-Institutional propensity score matched study.
Diabetes research and clinical practice2025PMID 40456414
Characteristics and Treatment Patterns of People Without Type 2 Diabetes Diagnoses Who Use Tirzepatide in the United States.
Clinical therapeutics2025PMID 40480878
Efficacy and safety of once-weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT-2 trial.
Diabetes, obesity & metabolism2025PMID 40490415
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status.
Obesity (Silver Spring, Md.)2025PMID 40491239Indexed under tirzepatide in PubMed
Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Obesity reviews2025PMID 40510020
Depression and suicide/self-injury signals for weight loss medications: A disproportionality analysis of semaglutide, liraglutide, and tirzepatide in FAERS database.
Journal of affective disorders2025PMID 40523410Indexed under tirzepatide in PubMed's chemical list
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.
Diabetes, obesity & metabolism2025PMID 40537987Indexed under tirzepatide in PubMed
Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide.
Annals of internal medicine2025PMID 40550133
Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial.
Nature medicine2025PMID 40555748
A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure-Response Relationship during Treatment of Obesity with Tirzepatide.
Clinical pharmacology and therapeutics2025PMID 40556483
Comparative Efficacy of Tirzepatide, Liraglutide, and Semaglutide in Reduction of Risk of Major Adverse Cardiovascular Events in Patients with Obstructive Sleep Apnea and Type 2 Diabetes: Real-World Evidence.
Annals of the American Thoracic Society2025PMID 40590655Indexed under tirzepatide in PubMed
Association of tirzepatide with erectile dysfunction in people with type 2 diabetes.
Journal of diabetes and its complications2025PMID 40614622
Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4.
Diabetes2025PMID 40633089Also indexed under tirzepatide as a PubMed major topic
Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study.
Diabetologia2025PMID 40637847